PMID- 37211499 OWN - NLM STAT- MEDLINE DCOM- 20230905 LR - 20230905 IS - 1545-7214 (Electronic) IS - 1064-7481 (Linking) VI - 31 IP - 10 DP - 2023 Oct TI - Lipopolysaccharide, Immune Biomarkers and Cerebral Amyloid-Beta Deposition in Older Adults With Mild Cognitive Impairment & Major Depressive Disorder. PG - 786-795 LID - S1064-7481(23)00288-9 [pii] LID - 10.1016/j.jagp.2023.04.014 [doi] AB - OBJECTIVE: Inflammatory activation and increased immune response to lipopolysaccharide occur in both depression and cognitive decline and may link these two conditions. We investigated whether lipopolysaccharide (LPS), LPS binding protein (LBP) and peripheral biomarkers of immune response were associated with increased cerebral deposition of amyloid-beta (Abeta) in older adults with mild cognitive impairment (MCI) and remitted major depressive disorder (rMDD). DESIGN: Cross-sectional analysis. SETTING: Five academic health centers in Toronto. PARTICIPANTS: Older adults with MCI with/without rMDD. MEASUREMENTS: We investigated the associations among serum LPS, LBP, biomarkers of inflammatory activation - Interleukin-6 (IL-6), C-reactive protein (CRP), monocyte chemoattractant protein-1 (MCP-1), and cerebral Abeta deposition quantified by positron emission tomography. RESULTS: Among 133 study participants (82 with MCI and 51 with MCI+rMDD) there was no association between LPS (beta - 0.17, p = 0.8) or LBP (beta - 0.11, p = 0.12) and global deposition of Abeta following adjustment for age, gender, and APOE genotype in multivariable regression analyses. LBP was positively correlated with CRP (r = 0.5, p <0.001) and IL-6 (r = 0.2, p = 0.02) but no inflammatory biomarker was associated with Abeta deposition; rMDD was not associated with deposition of Abeta (beta -0.09, p = 0.22). CONCLUSION: In this cross-sectional analysis, we did not find an association among LPS/LBP, immune biomarkers or rMDD and global deposition of Abeta. Future analyses should assess the longitudinal relationships between peripheral and central biomarkers of immune activation, depression and cerebral Abeta deposition. CI - Copyright (c) 2023 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved. FAU - Feng, Vivian AU - Feng V AD - Neuropsychopharmacology Research Group (VF, KL, NH, AK, ST, DG), Sunnybrook Research Institute, Toronto, Canada. FAU - Lanctot, Krista AU - Lanctot K AD - Neuropsychopharmacology Research Group (VF, KL, NH, AK, ST, DG), Sunnybrook Research Institute, Toronto, Canada; Department of Psychiatry (KL, NH, CEF, AJF, LM, BHM, BGP, TKR, NPV, AG-G, DG), Temerty Faculty of Medicine, University of Toronto, Toronto, Canada. FAU - Herrmann, Nathan AU - Herrmann N AD - Neuropsychopharmacology Research Group (VF, KL, NH, AK, ST, DG), Sunnybrook Research Institute, Toronto, Canada; Department of Psychiatry (KL, NH, CEF, AJF, LM, BHM, BGP, TKR, NPV, AG-G, DG), Temerty Faculty of Medicine, University of Toronto, Toronto, Canada. FAU - Kiss, Alex AU - Kiss A AD - Neuropsychopharmacology Research Group (VF, KL, NH, AK, ST, DG), Sunnybrook Research Institute, Toronto, Canada; Department of Health Policy, Management and Evaluation (AK), University of Toronto, Toronto, Canada. FAU - Fischer, Corinne E AU - Fischer CE AD - Department of Psychiatry (KL, NH, CEF, AJF, LM, BHM, BGP, TKR, NPV, AG-G, DG), Temerty Faculty of Medicine, University of Toronto, Toronto, Canada; Keenan Research Centre for Biomedical Science (CEF), St. Michael's Hospital, Toronto, Canada. FAU - Flint, Alastair J AU - Flint AJ AD - Department of Psychiatry (KL, NH, CEF, AJF, LM, BHM, BGP, TKR, NPV, AG-G, DG), Temerty Faculty of Medicine, University of Toronto, Toronto, Canada; Centre for Mental Health (AJF), University Health Network and University of Toronto, Toronto, Canada. FAU - Mah, Linda AU - Mah L AD - Department of Psychiatry (KL, NH, CEF, AJF, LM, BHM, BGP, TKR, NPV, AG-G, DG), Temerty Faculty of Medicine, University of Toronto, Toronto, Canada; Department of Psychiatry (LM, NPV), Baycrest Health Sciences Centre, Toronto, Canada; Rotman Research Institute (LM), Baycrest Health Sciences Centre, Toronto, Canada. FAU - Mulsant, Benoit H AU - Mulsant BH AD - Department of Psychiatry (KL, NH, CEF, AJF, LM, BHM, BGP, TKR, NPV, AG-G, DG), Temerty Faculty of Medicine, University of Toronto, Toronto, Canada; Adult Neurodevelopment and Geriatric Psychiatry Division (BHM, BGP, TKR, AG-G), Centre for Addiction and Mental Health, Toronto, Canada; Toronto Dementia Research Alliance (BMH, BGP, TKR, NPV), University of Toronto, Toronto, Canada. FAU - Pollock, Bruce G AU - Pollock BG AD - Department of Psychiatry (KL, NH, CEF, AJF, LM, BHM, BGP, TKR, NPV, AG-G, DG), Temerty Faculty of Medicine, University of Toronto, Toronto, Canada; Adult Neurodevelopment and Geriatric Psychiatry Division (BHM, BGP, TKR, AG-G), Centre for Addiction and Mental Health, Toronto, Canada; Toronto Dementia Research Alliance (BMH, BGP, TKR, NPV), University of Toronto, Toronto, Canada. FAU - Rajji, Tarek K AU - Rajji TK AD - Department of Psychiatry (KL, NH, CEF, AJF, LM, BHM, BGP, TKR, NPV, AG-G, DG), Temerty Faculty of Medicine, University of Toronto, Toronto, Canada; Adult Neurodevelopment and Geriatric Psychiatry Division (BHM, BGP, TKR, AG-G), Centre for Addiction and Mental Health, Toronto, Canada; Toronto Dementia Research Alliance (BMH, BGP, TKR, NPV), University of Toronto, Toronto, Canada. FAU - Tumati, Shankar AU - Tumati S AD - Neuropsychopharmacology Research Group (VF, KL, NH, AK, ST, DG), Sunnybrook Research Institute, Toronto, Canada. FAU - Verhoeff, Nicolaas Paul AU - Verhoeff NP AD - Department of Psychiatry (KL, NH, CEF, AJF, LM, BHM, BGP, TKR, NPV, AG-G, DG), Temerty Faculty of Medicine, University of Toronto, Toronto, Canada; Department of Psychiatry (LM, NPV), Baycrest Health Sciences Centre, Toronto, Canada; Toronto Dementia Research Alliance (BMH, BGP, TKR, NPV), University of Toronto, Toronto, Canada. FAU - Graff-Guerrero, Ariel AU - Graff-Guerrero A AD - Department of Psychiatry (KL, NH, CEF, AJF, LM, BHM, BGP, TKR, NPV, AG-G, DG), Temerty Faculty of Medicine, University of Toronto, Toronto, Canada; Adult Neurodevelopment and Geriatric Psychiatry Division (BHM, BGP, TKR, AG-G), Centre for Addiction and Mental Health, Toronto, Canada. FAU - Gallagher, Damien AU - Gallagher D AD - Neuropsychopharmacology Research Group (VF, KL, NH, AK, ST, DG), Sunnybrook Research Institute, Toronto, Canada; Department of Psychiatry (KL, NH, CEF, AJF, LM, BHM, BGP, TKR, NPV, AG-G, DG), Temerty Faculty of Medicine, University of Toronto, Toronto, Canada. Electronic address: Damien.gallagher@sunnybrook.ca. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20230429 PL - England TA - Am J Geriatr Psychiatry JT - The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry JID - 9309609 RN - 0 (Lipopolysaccharides) RN - 0 (Interleukin-6) RN - 0 (Amyloid beta-Peptides) RN - 0 (Biomarkers) SB - IM MH - Humans MH - Aged MH - *Depressive Disorder, Major/complications MH - Lipopolysaccharides MH - *Alzheimer Disease/psychology MH - Cross-Sectional Studies MH - Interleukin-6 MH - Amyloid beta-Peptides/metabolism MH - *Cognitive Dysfunction/complications MH - Positron-Emission Tomography MH - Biomarkers OTO - NOTNLM OT - Lipopolysaccharide OT - amyloid-beta OT - major depressive disorder EDAT- 2023/05/22 00:41 MHDA- 2023/09/05 06:42 CRDT- 2023/05/21 21:59 PHST- 2023/02/10 00:00 [received] PHST- 2023/04/21 00:00 [revised] PHST- 2023/04/24 00:00 [accepted] PHST- 2023/09/05 06:42 [medline] PHST- 2023/05/22 00:41 [pubmed] PHST- 2023/05/21 21:59 [entrez] AID - S1064-7481(23)00288-9 [pii] AID - 10.1016/j.jagp.2023.04.014 [doi] PST - ppublish SO - Am J Geriatr Psychiatry. 2023 Oct;31(10):786-795. doi: 10.1016/j.jagp.2023.04.014. Epub 2023 Apr 29.